- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of off-label biologicals in systemic lupus erythematosus
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 14, Issue 2, Pages 243-251
Publisher
Informa Healthcare
Online
2014-12-06
DOI
10.1517/14740338.2015.986455
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort
- (2014) K Takase et al. ANNALS OF THE RHEUMATIC DISEASES
- Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
- (2014) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Mefloquine Improved Progressive Multifocal Leukoencephalopathy in a Patient with Systemic Lupus Erythematosus
- (2014) Minako Beppu et al. INTERNAL MEDICINE
- Prolonged improvement of childhood onset systemic lupus erythematosus following systematic administration of rituximab and cyclophosphamide
- (2014) Thomas JA Lehman et al. Pediatric Rheumatology
- Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012: Table 1
- (2013) Daniel E Furst et al. ANNALS OF THE RHEUMATIC DISEASES
- Proposal for a new nomenclature of disease-modifying antirheumatic drugs: Table 1
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- New biologic therapy for systemic lupus erythematosus
- (2013) Hui Jen Ding et al. CURRENT OPINION IN PHARMACOLOGY
- Significant improvement following combination treatment with mefloquine and mirtazapine in a patient with progressive multifocal leukoencephalopathy after allogeneic peripheral blood stem cell transplantation
- (2013) Hitoshi Yoshida et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Hypogammaglobulinemia in pediatric systemic lupus erythematosus
- (2013) E Lim et al. LUPUS
- Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) – results from a nationwide cohort in Germany (GRAID)
- (2013) M Witt et al. LUPUS
- Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Charlotte Hua et al. ARTHRITIS CARE & RESEARCH
- Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden
- (2013) P. Raaschou et al. BMJ-British Medical Journal
- Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve-Month, Randomized, Double-Blind Study
- (2013) Richard Furie et al. Arthritis & Rheumatology
- T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH Study
- (2012) Parakkal Deepak et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Forget personalised medicine and focus on abating disease activity
- (2012) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials
- (2012) Susan Manzi et al. ANNALS OF THE RHEUMATIC DISEASES
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
- (2012) George K Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation
- (2012) Ramalingam Bethunaickan et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
- (2012) Michael E. Weinblatt et al. ARTHRITIS AND RHEUMATISM
- Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis
- (2012) M. Bonelli et al. ARTHRITIS AND RHEUMATISM
- The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment
- (2012) J. Listing et al. RHEUMATOLOGY
- Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
- (2011) A. Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
- (2011) David B. Clifford ARCHIVES OF NEUROLOGY
- Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): Long-term followup of a multicenter longitudinal cohort
- (2011) Francisco Silva et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation
- (2011) M. Konsta et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Current state of evidence on ‘off-label’ therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland – a consensus report
- (2011) M Aringer et al. LUPUS
- Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label
- (2011) Cándido Díaz-Lagares et al. ARTHRITIS RESEARCH & THERAPY
- Treatment of Mild, Moderate, and Severe Lupus Erythematosus: Focus on New Therapies
- (2011) Maria Dall’Era et al. Current Rheumatology Reports
- Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
- (2010) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial
- (2010) J. T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry
- (2010) Benjamin Terrier et al. ARTHRITIS AND RHEUMATISM
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study
- (2010) Gabor G. Illei et al. ARTHRITIS AND RHEUMATISM
- Rituximab Therapy in Lupus Nephritis: Current Clinical Evidence
- (2010) Manuel Ramos-Casals et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
- (2010) R. F. van VOLLENHOVEN et al. JOURNAL OF RHEUMATOLOGY
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data
- (2010) Johan Askling et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Immunologic parameters and viral infections in patients desensitized with intravenous immunoglobulin and rituximab
- (2010) Shili Ge et al. TRANSPLANT IMMUNOLOGY
- Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
- (2009) R Westhovens et al. ANNALS OF THE RHEUMATIC DISEASES
- A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patients
- (2009) Tim Y.-T. Lu et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
- (2009) K. R. Carson et al. BLOOD
- Accelerated Pathological and Clinical Nephritis in Systemic Lupus Erythematosus-Prone New Zealand Mixed 2328 Mice Doubly Deficient in TNF Receptor 1 and TNF Receptor 2 via a Th17-Associated Pathway
- (2009) N. Jacob et al. JOURNAL OF IMMUNOLOGY
- Adverse events and efficacy of TNF- blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients
- (2009) M. Aringer et al. RHEUMATOLOGY
- Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment
- (2008) T A Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: Are patients with systemic lupus erythematosus at particular risk?
- (2008) Eamonn S. Molloy et al. AUTOIMMUNITY REVIEWS
- Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders
- (2008) HF Petereit et al. Multiple Sclerosis Journal
- The role of tumor necrosis factor-alpha in systemic lupus erythematosus
- (2008) Martin Aringer et al. ARTHRITIS RESEARCH & THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now